An Intervention Delivered by App Instant Messaging to Increase Use of Effective Contraception Among Young Women in Bolivia

Overview

This randomised controlled trial will establish the effect a contraceptive intervention delivered by mobile phone app instant messaging on use of effective contraception in Bolivia. Woman aged 16-24 will be randomised to have access to Centro de Investigacion, Educacion y Servicios's sexual and reproductive health app (control) or the app plus 0-3 instant messages a day for 4 months (intervention). Participants will complete a questionnaire at baseline and 4 month follow-up.

Full Title of Study: “A Randomised Controlled Trial of an Intervention Delivered by App Instant Messaging to Increase Use of Effective Contraception Among Young Women in Bolivia”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: January 31, 2018

Interventions

  • Behavioral: Contraceptive instant messages
    • Contraceptive Instant messages
  • Other: Mobile phone app
    • Mobile phone app

Arms, Groups and Cohorts

  • Experimental: Intervention
    • App plus the contraceptive instant messages
  • Placebo Comparator: Control
    • App only

Clinical Trial Outcome Measures

Primary Measures

  • Use of effective contraception
    • Time Frame: 4 months
    • The proportion reporting current use of effective contraception (pill, intrauterine device, injection, implant, patch)
  • Acceptability of at least one method of effective contraception
    • Time Frame: 4 months
    • The proportion reporting that at least one method of effective contraception is acceptable (pill, intrauterine device, injection, implant, patch)

Secondary Measures

  • Acceptability of individual effective contraceptive methods
    • Time Frame: 4 months
    • The proportion reporting that individual methods of effective contraception are acceptable (pill, intrauterine device, injection, implant, patch)
  • Discontinuation of effective contraception
    • Time Frame: 4 months
    • The proportion reporting use of effective contraception at any time during the 4 months (pill, intrauterine device, injection, implant, patch)
  • Service uptake
    • Time Frame: 4 months
    • The proportion reporting attending a sexual health service during the 4 months
  • Unintended pregnancy
    • Time Frame: 4 months
    • The proportion reporting that they became pregnant and did not want to become pregnant during the study
  • Induced abortion
    • Time Frame: 4 months
    • The proportion reporting having an abortion during the study

Participating in This Clinical Trial

Inclusion Criteria

  • Aged 16-24 – Own a personal Android mobile phone – Live in El Alto or La Paz Bolivia – Sexually active – Not using the pill, implant, injection, intrauterine device or patch – Want to avoid a pregnancy Exclusion Criteria:
  • Cannot read Spanish
  • Gender Eligibility: Female

    Minimum Age: 16 Years

    Maximum Age: 24 Years

    Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

    Investigator Details

    • Lead Sponsor
      • London School of Hygiene and Tropical Medicine
    • Collaborator
      • International Planned Parenthood Federation
    • Provider of Information About this Clinical Study
      • Sponsor
    • Overall Official(s)
      • Caroline Free, PhD, Principal Investigator, London School of Hygiene and Tropical Medicine

    Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

    At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.